Overview

GM03 - Platelet RNA Signatures of Aspirin

Status:
Completed

Trial end date:
2016-12-05

Target enrollment:

Participant gender:

Summary

This study will involve healthy volunteers and patients with Type 2 diabetes. Eligible healthy volunteers will be invited to enroll into one of two protocols (A or B) and eligible patients with diabetes will be enrolled into protocol A.

Phase:

Early Phase 1

Details

Lead Sponsor:

Duke University

Treatments:

Aspirin
Ticagrelor